American Healthcare REIT, Inc. (AHR) stock
AHRNYSEReal Estate Investment TrustsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30154% above fair value
$57.94−0.13 (-0.22%)
Close on Nov 17, 2026Market cap $12.63BP/E 85.2Yield 1.73%
American Healthcare REIT ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
American Healthcare REIT's ebitda for the twelve months ending Jun 30, 2026 was $723.83M, up 28.2% year over year. For fiscal 2025 it was $602.72M, up 11.1% from the year before. The highest annual figure on record is $602.72M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $602.72M | +11.1% |
| FY2024 | Dec 31, 2024 | $542.73M | +10.9% |
| FY2023 | Dec 31, 2023 | $489.44M | +4.2% |
| FY2022 | Dec 31, 2022 | $469.92M | +35.6% |
| FY2021 | Dec 31, 2021 | $346.53M | +9.3% |
| FY2020 | Dec 31, 2020 | $317.13M | -4.7% |
| FY2019 | Dec 31, 2019 | $332.81M | – |
| FY2016 | Dec 31, 2016 | -$3.71M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $209.36M | +44.2% |
| Q1 FY2026 | Mar 31, 2026 | $192.57M | +42.0% |
| Q4 FY2025 | Dec 31, 2025 | $166.90M | +14.3% |
| Q3 FY2025 | Sep 30, 2025 | $155.00M | +12.5% |
| Q2 FY2025 | Jun 30, 2025 | $145.17M | +8.4% |
| Q1 FY2025 | Mar 31, 2025 | $135.65M | +8.6% |
| Q4 FY2024 | Dec 31, 2024 | $146.04M | +13.7% |
| Q3 FY2024 | Sep 30, 2024 | $137.78M | +10.8% |
| Q2 FY2024 | Jun 30, 2024 | $133.96M | +7.1% |
| Q1 FY2024 | Mar 31, 2024 | $124.94M | +12.0% |
| Q4 FY2023 | Dec 31, 2023 | $128.48M | +5.2% |
| Q3 FY2023 | Sep 30, 2023 | $124.34M | +8.8% |
| Q2 FY2023 | Jun 30, 2023 | $125.07M | +6.4% |
| Q1 FY2023 | Mar 31, 2023 | $111.56M | -3.8% |
| Q4 FY2022 | Dec 31, 2022 | $122.12M | -4.6% |
| Q3 FY2022 | Sep 30, 2022 | $114.25M | +45.0% |
| Q2 FY2022 | Jun 30, 2022 | $117.55M | +54.9% |
| Q1 FY2022 | Mar 31, 2022 | $116.00M | +81.8% |
| Q4 FY2021 | Dec 31, 2021 | $128.01M | +3562.6% |
| Q3 FY2021 | Sep 30, 2021 | $78.81M | +3755.7% |
| Q2 FY2021 | Jun 30, 2021 | $75.91M | – |
| Q1 FY2021 | Mar 31, 2021 | $63.80M | – |
| Q2 FY2017 | Jun 30, 2017 | $3.50M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.04M | – |
| Q4 FY2016 | Dec 31, 2016 | -$973.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.97M | – |
See a number that looks wrong?